Please login to the form below

Not currently logged in
Email:
Password:

Lothian pharmacies off cessation target

A strategy by NHS Lothian to move much of its smoking cessation services into pharmacies is well behind schedule

A strategy by NHS Lothian - one of the 15 regions of NHS Scotland - to move much of its region's smoking cessation services into pharmacies is well behind schedule on its targets, according to a presentation to the NHS Lothian board members by lead officers Mike Massarro-Mallinson and Fiona Hume.

Massarro-Mallinson and Hume explained that while it had been anticipated that pharmacies would deliver 40 per cent of the target, to date they have only contributed 8 per cent of successful outcomes achieved. 

This is despite a series of measures being outlined to make it happen, such as one-to-one help for quitters who are a month into kicking their habit, a significant advertising campaign signposting that the pharmacy scheme is underway and a pilot scheme which sees city chemists offer impromptu check-ups for harassed commuters.

Following these recent findings, the Lothian health board has vowed to provide extra training to community pharmacy staff in a bid to improve their skills in smoking cessation support and heed NHS Scotland's recent call to local health chiefs to obtain 11,000 successful quitters by 2011.

Despite the poor return from pharmacies however, 44 per cent more people attempted to stop smoking in the Lothians with the help of medics last year than the figures for 2007 reveal.

22nd June 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...

Infographics